Marchés français ouverture 6 h 32 min
  • Dow Jones

    30 932,37
    -469,63 (-1,50 %)
     
  • Nasdaq

    13 192,35
    +72,95 (+0,56 %)
     
  • Nikkei 225

    29 555,18
    +589,17 (+2,03 %)
     
  • EUR/USD

    1,2098
    +0,0010 (+0,08 %)
     
  • HANG SENG

    28 980,21
    0,00 (0,00 %)
     
  • BTC-EUR

    38 220,10
    -455,01 (-1,18 %)
     
  • CMC Crypto 200

    923,34
    -9,80 (-1,05 %)
     
  • S&P 500

    3 811,15
    -18,19 (-0,48 %)
     

Allergy Drugs Market Research Report by Type, by Treatment, by Distribution Channels - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5 min de lecture

Allergy Drugs Market Research Report by Type (Drug Allergy, Food Allergy, and Inhaled Allergy), by Treatment (Anti-allergy Drugs and Immunotherapy), by Distribution Channels - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Allergy Drugs Market Research Report by Type, by Treatment, by Distribution Channels - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06025420/?utm_source=GNW

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Allergy Drugs Market is expected to grow from USD 23,486.31 Million in 2020 to USD 33,642.94 Million by the end of 2025.
2. The Global Allergy Drugs Market is expected to grow from EUR 20,593.24 Million in 2020 to EUR 29,498.76 Million by the end of 2025.
3. The Global Allergy Drugs Market is expected to grow from GBP 18,307.43 Million in 2020 to GBP 26,224.46 Million by the end of 2025.
4. The Global Allergy Drugs Market is expected to grow from JPY 2,506,584.42 Million in 2020 to JPY 3,590,554.21 Million by the end of 2025.
5. The Global Allergy Drugs Market is expected to grow from AUD 34,105.24 Million in 2020 to AUD 48,854.02 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Allergy Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Allergy Drugs Market studied across Drug Allergy, Food Allergy, and Inhaled Allergy.

Based on Treatment, the Allergy Drugs Market studied across Anti-allergy Drugs and Immunotherapy. The Anti-allergy Drugs further studied across Antihistamines, Corticosteroids, and Leukotriene Inhibitors. The Immunotherapy further studied across Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT).

Based on Distribution Channels, the Allergy Drugs Market studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores.

Based on Geography, the Allergy Drugs Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy Drugs Market including AbbVie Inc., Aimmune Therapeutics, Inc, ALK-Abelló A/S, Allergy Therapeutics, Amneal Pharmaceuticals PLC, Astra Biotech GmbH, AstraZeneca PLC, Aurobindo Pharma, Bayer AG, Cadila Healthcare Limited, Chongqing Huapont Pharmaceutical Co., Ltd, Cipla Inc, Dr. Reddy’s Laboratories Ltd, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, HAL Allergy B.V., Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc, LETI Pharma GmBH, Lupin Limited, Magna Pharmaceuticals, Inc., Merck & Co., Inc, Mylan N.V, Novartis AG, Sanofi SA, Stallergenes Greer Ltd, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Allergy Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Allergy Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Allergy Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Allergy Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Allergy Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Allergy Drugs Market?
Read the full report: https://www.reportlinker.com/p06025420/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001